A Single-Institutional, Phase II, Open-label, Single Arm Trial of Famitinib Malate in in HER2-negative Metastatic Breast Cancer
Phase of Trial: Phase II
Latest Information Update: 01 Aug 2014
At a glance
- Drugs Famitinib (Primary)
- Indications Advanced breast cancer
- Focus Therapeutic Use
- 01 Nov 2013 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 29 Mar 2013 Planned End Date changed from 1 Mar 2013 to 1 Jul 2014 as reported by ClinicalTrials.gov.
- 07 Aug 2012 New trial record